Stomach Cancer Trial, Recruiting NCT06995898 Sponsor: National Cancer Institute (NCI) Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06995898
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 45 and 75 years old
  • You agree to give blood samples for possible cancer testing when you join the study and again one year later
  • You agree to let the study team access relevant information from your medical records
  • You are able to understand and complete consent forms and questionnaires in English, Spanish, or Arabic (note: availability of Spanish and Arabic may depend on your specific study location)

Who may not be able to join:

  • You have been diagnosed with a solid tumor cancer or blood cancer in the last 5 years, whether or not you received treatment (note: people with a history of certain very early-stage or surface-level cancers, such as early breast, cervical, or skin cancers of specific types, may still be eligible — confirm with trial site)
  • You are currently going through tests or follow-up to check whether you have cancer
  • You are already taking part in another study testing an investigational cancer screening test or device
  • You are currently pregnant or breastfeeding, or you are planning to become pregnant in the next year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 June 2025
Est. completion
31 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of enrollment onto study; Proportion of participants who complete baseline and follow-up questionnaires within 60 days of receipt; Proportion of participants who provide the required blood sample for year 1 for Multi-Cancer Detection (MCD) testing within 90 days of recommended time point; Proportion of participants considered lost to follow-up within 2 years of randomization; Representative enrollment; Staggered start of intervention arm 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov